EXTRACELLULAR HISTONES ENHANCE FACTOR XA MEDIATED PROTHROMBIN ACTIVATION WITHOUT PHOSPHOLIPID REQUIREMENT

EHA Library, Yasmina Sahraoui, 133660

PHORBOL 12-MYRISTATE-13-ACETATE INDUCES VON WILLEBRAND FACTOR PROPEPTIDE RELEASE FROM ENDOTHELIAL CELLS FROM 2 DISTINCT COMPARTMENTS

EHA Library, Ruben Bierings, 133661

NEWLY DIAGNOSED PLASMA CELL DYSCRASIAS ARE ASSOCIATED WITH ENHANCED TF PATHWAY ACTIVATION, THROMBIN GENERATION AND INCREASED CONCENTRATION OF PROCOAGULANT MICROPARTICLES

EHA Library, Despina Fotiou, 133662

ROLE OF ROTATIONAL THROMBELASTOMETRY (ROTEM®) IN RAPID ESTIMATION OF RIVAROXABAN DRUG LEVEL

EHA Library, Hun Chuah, 133663

PLATELET DERIVED MICROPARTICLES, AGGREGATES AND MARKERS OF IMMUNE ACTIVATION AND DISEASE PROGRESSION IN HIV INFECTED TREATMENT NAIVE ASYMPTOMATIC INDIVIDUALS.

EHA Library, Bongani Nkambule, 133664

INCIDENCE OF PERIPHERAL CIRCULATING CELLS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PHENOTYPE A FIRST EPISODE OF CEREBRAL SINUS VEIN THROMBOSIS: RESULTS FROM A PROSPECTIVE MULTICENTER STUDY

EHA Library, Mariasanta Napolitano, 133666

REGULATION OF WEIBEL-PALADE BODY EXOCYTOSIS FROM ENDOTHELIAL CELLS BY SYNTAXIN-3 AND STXBP5 CONTAINING SNARE COMPLEXES.

EHA Library, Ruben Bierings, 133667

COMPARISON OF QUALITY OF LIFE BETWEEN LONG-TERM SURVIVORS OF INDOLENT AND AGGRESSIVE LYMPHOMA: RESULTS OF A SINGLE CENTER PROSPECTIVE COHORT STUDY

EHA Library, Seok Jin Kim, 133668

IMPACT OF IRON DEFICIENCY ON QUALITY OF LIFE AND WORK CAPACITY OF WOMEN

EHA Library, Lucilia Caramelo, 133669

IRON DEFICIENCY: UNDERSTANDING PERCEPTIONS OF SUFFERERS AND THE GENERAL PUBLIC

EHA Library, Lucilia Caramelo, 133670

CIRS COMORBIDITY SCORE IS USEFUL FOR TREATMENT CHOICE AND PREDICT TREATMENT OUTCOME IN ELDERLY PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Driss Chaoui, 133671

THE RELATIVE BURDEN OF AL AMYLOIDOSIS ON HEALTH-RELATED QUALITY OF LIFE

EHA Library, Spencer Guthrie, 133672

OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA IN A LARGE COHORT INSIDE A PHASE 1 CLINIC DEPARTMENT.

EHA Library, Jean-Marie Michot, 133673

QUALITY OF LIFE IN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: CHILDREN’S AND PARENTS’ PERCEPTION

EHA Library, Hale Oren, 133674

HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN LONGITUDINAL STUDIES INCLUDING MULTIPLE MYELOMA PATIENTS: A CRITICAL REVIEW OF INTERPRETING CHANGES OF SCORES OBTAINED BY EORTC QLQ-C30

EHA Library, Lene Kongsgaard Nielsen, 133675

AAV-MEDIATED GENE THERAPY FOR HEMOPHILIA B-EXPRESSION AT THERAPEUTIC LEVELS WITH LOW VECTOR DOSES

EHA Library, Spencer Sullivan, 135342

PILLAR-2: PHASE 3 STUDY OF ADJUVANT EVEROLIMUS VERSUS PLACEBO IN PATIENTS WITH POOR-RISK DIFFUSE LARGE B-CELL LYMPHOMA WHO ACHIEVED COMPLETE REMISSION WITH RITUXIMAB-COMBINED CHEMOTHERAPY

EHA Library, Franco Cavalli, 135341

RESULTS FROM ENESTFREEDOM: TREATMENT-FREE REMISSION (TFR) FOLLOWING FRONTLINE NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Giuseppe Saglio, 135340

IMGN632: A NOVEL ANTIBODY-DRUG CONJUGATE (ADC) OF A CD123-TARGETING ANTIBODY WITH A POTENT DNA-ALKYLATOR IS HIGHLY ACTIVE IN PRECLINICAL MODELS OF AML WITH POOR PROGNOSIS

EHA Library, Yelena Kovtun, 135339

NOVEL LEUKEMIA STEM CELL-TARGETED THERAPY FOR ACUTE MYELOID LEUKEMIA BASED ON DUAL INHIBITION OF EZH1/EZH2

EHA Library, Issay Kitabayashi, 135338

RELATIVE BENEFIT FOR INTENSIVE VERSUS NON-INTENSIVE INDUCTION THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) USING A COMPOSITE, AGE-COMORBIDITY-CYTOGENETIC, MODEL

EHA Library, Mohamed Sorror, 135337

FIRST ANALYSIS OF THE MULTICENTRE, BLINDED, PLACEBO-CONTROLLED PRE-GVHD CLINICAL-TRIAL FOR PREDICTION AND PRE-EMPTIVE TREATMENT OF ACUTE GVHD IN 210 OF 260 PATIENTS

EHA Library, Eva Weissinger, 135281

ROMIPLOSTIM IN SPLENECTOMIZED (SPLNX) AND NONSPLENECTOMIZED (NONSPLNX) PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Douglas B Cines, 135276

GENERATION OF CHIMERIC ANTIGEN RECEPTOR - MODIFIED MEMORY STEM CELL CD8+ T LYMPHOCYTES FROM NAIVE PRECURSORS BY MODULATION OF WNT/BETA-CATENIN PATHWAY OR INHIBITION OF AKT-SIGNALING

EHA Library, Udo Hartwig, 135271

EXPRESSION, REGULATION, AND FUNCTIONAL ROLE OF HERMES ADHESION RECEPTOR CD44 IN NEOPLASTIC MAST CELLS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Niklas Mueller, 135266

PHASE I/II STUDY OF VOSAROXIN AND DECITABINE IN NEWLY DIAGNOSED OLDER PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Naval Daver, 135261

EARLY IMMATURE T-ALL AS DETERMINED BY ABSENCE OF BI-ALLELIC DELETION AT THE TCR GAMMA LOCUS IS NOT AN ADVERSE PROGNOSTIC FACTOR ON THE MRC UKALL2003 TRIAL

EHA Library, Nadine Farah, 135256

MODELLING PONATINIB RESISTANCE IN BCR-ABL1+ CELL LINES: IMPLICATIONS FOR PONATINIB THERAPY

EHA Library, Liubov Poluskina, 135251

BET INHIBITORS SUPPRESS PD-L1 TRANSCRIPTION TO ENHANCE ANTI-TUMOUR IMMUNITY AND IMMUNOTHERAPEUTIC APPROACHES

EHA Library, Simon Hogg, 135246

LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ANTHRACYCLINE MONOTHERAPY AND ATRA-BASED PETHEMA PROTOCOLS

EHA Library, David Martinez-Cuadron, 135242

RESULTS FROM SCHOLAR-1: OUTCOMES IN PATIENTS WITH REFRACTORY AGGRESSIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Christian Gisselbrecht, 135237

SEQUENTIAL HIGH-DOSE CYTARABINE PLUS IDARUBICIN IMPROVES REMISSION RATE AND SURVIVAL DURATION IN ADULT ACUTE MYELOGENOUS LEUKEMIA (AML): RANDOMIZED TRIAL OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)

EHA Library, Renato Bassan, 135241

PHASE 1B RESULTS OF IDASANUTLIN + CYTARABINE (ARA-C) IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)

EHA Library, Cristina Pappayannidis, 135260

TRENDS IN THE USE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT

EHA Library, Sebastian Giebel, 135280

LONG-TERM HEMATOLOGIC, BIOMARKER, AND BONE RESPONSE TO ORAL ELIGLUSTAT IN PATIENTS WITH GAUCHER DISEASE TYPE 1: RESULTS FROM A PHASE 2 AND TWO PHASE 3 TRIALS

EHA Library, Elena Lukina, 135275

MESENCHYMAL STROMAL CELLS GENERATED FROM POOLED MONONUCLEAR CELLS OF MULTIPLE BONE MARROW DONORS AS A RESCUE THERAPY FOR SEVERE STEROID-REFRACTORY GRAFT VERSUS HOST DISEASE: A MULTICENTER SURVEY

EHA Library, Zyrafete Kuçi, 135270

PHASE 1 TRIAL OF CUDC-907, A NOVEL, ORAL DUAL INHIBITOR OF HDAC AND PI3K: UPDATED ASSESSMENT OF PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE EXPRESSOR LYMPHOMA

EHA Library, Anas Younes, 135236

INOTUZUMAB OZOGAMICIN FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA IN THE GLOBAL PHASE 3 RANDOMIZED CONTROLLED INO-VATE TRIAL: EFFICACY AND SAFETY BY PRIOR THERAPY

EHA Library, Daniel J DeAngelo, 135255

B CELL-SPECIFIC CONDITIONAL EXPRESSION OF MYD88P.L252P LEADS TO THE DEVELOPMENT OF DIFFUSE LARGE B CELL LYMPHOMA IN MICE

EHA Library, Gero Knittel, 135245

CALRETICULIN MUTANT PROTEINS INDUCE MEGAKARYOCYTIC SIGNALING TO TRANSFORM HEMATOPOIETIC CELLS AND UNDERGO ACCELERATED DEGRADATION AND GOLGI-MEDIATED SECRETION

EHA Library, Nicolas Chatain, 135265

THE ADVERSE EFFECTS OF CANCEROUS INHIBITOR OF PROTEIN PHOSPHATASE 2A, ARE LINKED WITH REDUCTION OF FUNCTIONAL B56GAMMA, A REGULATORY SUBUNIT OF PROTEIN PHOSPHATASE 2A, IN CHRONIC MYELOID LEUKAEMIA

EHA Library, James Austin, 135250

INFUSION OF BPX-501 (DONOR T CELLS TRANSDUCED WITH THE IC9 SUICIDE GENE) AFTER ?/? T-CELL DEPLETED HAPLO-HSCT IN CHILDREN WITH ACUTE LEUKEMIA: PRELIMINARY RESULTS OF A PHASE I-II TRIAL.

EHA Library, Alice Bertaina, 135279

SGN-CD33A IN COMBINATION WITH HYPOMETHYLATING AGENTS: A NOVEL, WELL-TOLERATED REGIMEN WITH HIGH REMISSION RATE IN OLDER PATIENTS WITH AML

EHA Library, Amir Fathi, 135259

IDENTIFYING THE GENETIC BASIS OF RARE BLEEDING AND PLATELET DISORDERS USING SYSTEMATIC PHENOTYPING AND GENOME SEQUENCING

EHA Library, Ernest Turro, 135274

A BIOCLINICAL PROGNOSTIC MODEL INCORPORATING MYC AND BCL2 PREDICTS OUTCOME TO SALVAGE THERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: AN NCIC CTG LY12 CORRELATIVE SCIENCE STUDY.

EHA Library, Douglas A Stewart, 135235

REGENERATION OF WT1 SPECIFIC CTLS UTILIZING IPSC TECHNOLOGY

EHA Library, Takuya Maeda, 135269

RISK ADAPTED THERAPY FOR ACUTE MYELOID LEUKEMIA (AML) BASED ON GENETIC DATA AND MINIMAL RESIDUAL DISEASE: RESULTS OF THE AML12 TRIAL OF THE CETLAM GROUP IN ADULTS UP TO THE AGE OF 70 YEARS.

EHA Library, Jorge Sierra, 135240

IMPACT OF DISEASE BURDEN ON LONG-TERM OUTCOME OF CD19-TARGETED CAR MODIFIED T CELLS IN ADULT PATIENTS WITH RELAPSED B-ALL

EHA Library, Jae H. Park, 135254

THE JAK2V617F MUTATION IS A POTENTIAL TARGET FOR CANCER IMMUNE THERAPY

EHA Library, Morten Holmström, 135264

DYNAMICS OF SOMATIC MUTATIONS COMMONLY DETECTED IN OTHER MYELOID NEOPLASMS BEYOND THE BCR-ABL GENE REARRANGEMENT IN RESPONSE TO TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA

EHA Library, Taehyung Kim, 135249

ACUTE GRAFT VERSUS HOST DISEASE GRADE I : FINAL ANALYSIS OF A GITMO RANDOMIZED TRIAL OF PREDNISOLONE VS NO TREATMENT

EHA Library, Andrea Bacigalupo, 135278

FINAL SAFETY AND EFFICACY RESULTS FROM THE EXTEND STUDY: TREATMENT WITH ELTROMBOPAG (EPAG) IN ADULTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP)

EHA Library, Lori Smith, 135273

CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS.

EHA Library, Jeffrey Lancet, 135258

TUMOR NECROSIS FACTOR RECEPTOR 2 MAY BE REQUIRED FOR CLONAL DOMINANCE OF JAK2 V617F MUTANT OVER JAK2 WILDTYPE CELLS

EHA Library, Michael W Deininger, 135263

SURVIVAL OF DLBCL PATIENTS IN FIRST REMISSION RELATIVE TO A MATCHED BACKGROUND POPULATION

EHA Library, Lasse Hjort Jakobsen, 135234

MONOSOMAL KARYOTYPE AND TRISOMY 8 ARE POOR PROGNOSTIC FACTORS IN PEDIATRIC AML: AN AML-BFM 2004 TRIAL REPORT ON GENOTYPE-OUTCOME CORRELATIONS

EHA Library, Mareike Rasche, 135239

THE HIGHLY CLINICAL EFFICACY AND SAFETY OF THE AUTOLOGOUS ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS IMMUNOTHERAPY FOR 26 CASES WITH HEAVILY TREATED REFRACTORY B ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jing Pan, 135268

DURABLE REMISSIONS AFTER MONOTHERAPY WITH CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS IN CHILDREN AND YOUNG ADULTS WITH RELAPSED/REFRACTORY ALL

EHA Library, Shannon Maude, 135253

DECODING THE ENTIRE DNA METHYLOME OF MANTLE CELL LYMPHOMA: NEW BIOLOGICAL AND CLINICAL INSIGHTS

EHA Library, Renée Beekman, 135244

IDENTIFYING, TRACKING AND VISUALIZATION CML BLAST CRISIS STEM/PROGENITORS CELLS BASED ON SINGLE-CELL MASS CYTOMETRY ANALYSIS

EHA Library, Hongsheng Zhou, 135248

ROLE OF THE MSC-DERIVED EXOSOMAL AND ENDOGENOUS JAK2-SET/PP2A-?-CATENIN-MODULATOR MIR-300 IN LEUKEMIC STEM/PROGENITOR PROLIFERATION AND SURVIVAL IN CML.

EHA Library, Danilo Perrotti, 135247

HIGH THROUGHPUT SEQUENCING AS A MEASURE OF EARLY RESPONSE TO THERAPY IN CHILDHOOD ALL

EHA Library, Ilan Kirsch, 135252

GENETIC LANDSCAPE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Kenichi Yoshida, 135243

PHASE III RANDOMIZED TRIAL OF VOLASERTIB PLUS LOW-DOSE CYTARABINE (LDAC) VERSUS PLACEBO PLUS LDAC IN PATIENTS AGED ?65 YEARS WITH PREVIOUSLY UNTREATED AML, INELIGIBLE FOR INTENSIVE THERAPY

EHA Library, Hartmut Döhner, 135257

IMPROVED SURVIVAL IN PEDIATRIC ACUTE MYELOID LEUKEMIA: A REPORT FROM AML-BFM TRIALS 1987-2011.

EHA Library, Mareike Rasche, 135238

RANDOMIZED PHASE III STUDY OF EARLY RITUXIMAB INTENSIFICATION IN COMBINATION WITH CHOP14 FOLLOWED BY RITUXIMAB OR NO MAINTENANCE IN DIFFUSE LARGE B-CELL LYMPHOMA: A HOVON-NORDIC LYMPHOMA GROUP STUDY

EHA Library, Pieternella (Elly) Lugtenburg, 135233

GENETIC VARIATION AT HBS1L-MYB AND GFI1B-GTF3C5 INFLUENCES WHETHER JAK2 V617F MUTATED MPN PRESENT WITH ET OR PV

EHA Library, Nick Cross, 135262

DISREGULATED MEGAKARYOCYTE MIGRATION AND MATURATION IS POSSIBLY DUE TO IMPAIRED BONE MARROW SYMPATHETIC NERVETHROUGH NESTIN+ MESENCHYMAL STEM CELL IN CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Xiaohui Zhang, 135272

PD-1 GENOTYPE OF THE DONOR AND ACUTE GRAFT-VERSUS-HOST DISEASE AFTER HLA-IDENTICAL SIBLING DONOR STEM CELL TRANSPLANTATION

EHA Library, Nazly Santos, 135277

TUMOR-SPECIFIC GLYCOSYLATED CD43 IS A NOVEL AND HIGHLY SPECIFIC TARGET FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Mette Hazenberg, 135267

Targeted genome editing in hematopoietic stem cells

EHA Library, Luigi Naldini, 137089

Immune checkpoint blockade in lymphoma

EHA Library, Philippe Armand, 137088

Jean Bernard Lifetime Achievement Award: Acceptance Speech - Iron, erythropoiesis and beyond

EHA Library, Clara Camaschella, 137085

CLONAL ORIGIN OF THERAPY-RELATED MYELOID NEOPLASMS

EHA Library, Koichi Takahashi, 135202

THERAPEUTIC IMPACT OF TAK-1 INHIBITION ON TUMOR GROWTH AND BONE DESTRUCTION IN MYELOMA

EHA Library, Masahiro Okabe, 135207

THREE CASES OF CYCLIC NEUTROPENIA WITH ACQUIRED CSF3R MUTATIONS, ONE DEVELOPING AML

EHA Library, Cornelia Zeidler, 135232

ANALYSIS OF SECONDARY NEOPLASIAS AFTER HIGH DOSE THERAPY SUPPORTED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN FOLICULAR LYMPHOMA PATIENTS. A LONG TERM FOLLOW-UP ANALYSIS FROM THE GELTAMO REGISTRY.

EHA Library, Ana Jiménez Ubieto, 135197

THALIDOMIDE FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA: EFFICACY AND SAFETY OF LONG-TERM TREATMENT

EHA Library, Rosangela Invernizzi, 135227

EFFECTS OF AG-348, A PYRUVATE KINASE ACTIVATOR, ON ANEMIA AND HEMOLYSIS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY: EARLY DATA FROM THE DRIVE PK STUDY

EHA Library, Rachael F Grace, 135222

LOSS OF FUNCTION SETD2 MUTATIONS LEAD TO RESISTANCE TO DNA DAMAGING CHEMOTHERAPY IN LEUKEMIA

EHA Library, Josephine Kahn, 135217

ALLELES OF SNPS IN REGULATORY REGIONS OF SLC22A4 AND SLC22A5 GENES ARE SIGNIFICANTLY ASSOCIATED WITH STABLE MAJOR MOLECULAR RESPONSE TO IMATINIB FIRST LINE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Katerina Machova, 135192

ACALABRUTINIB, A SECOND-GENERATION BRUTON TYROSINE KINASE (BTK) INHIBITOR, IN PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, William Wierda, 135187

ACTIVATION OF THE THROMBOPOIETIN RECEPTOR BY MUTANT CALRETICULIN IN CALR-MUTANT MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Marito Araki, 135212

SF3B1 MUTATIONS IN MDS-RS ARISE IN MULTIPOTENT HEMOPOETIC STEM CELLS

EHA Library, Teresa Mortera-Blanco, 135201

PD-1 BLOCKADE ENHANCES THE EFFICACY OF ELOTUZUMAB IN MOUSE TUMOR MODELS

EHA Library, Natalie Bezman, 135206

HSC GENETIC HETEROGENEITY DETERMINES CLONAL DYNAMICS IN PMF

EHA Library, Ioanna Triviai, 135211

NEXT GENERATION TARGETED SEQUENCING IMPROVED THE PRECISE DIAGNOSIS OF PEDIATRIC APLASTIC ANEMIA /INHERITED BONE MARROW FAILURE SYNDROMES

EHA Library, Wenbin An, 135231

FIRST PROSPECTIVE RESULTS OF JOINT DISTRACTION IN SEVERE HEMOPHILIC ANKLE ARTHROPATHY

EHA Library, Lize van Vulpen, 135226

OBINUTUZUMAB PLUS BENDAMUSTINE VERSUS BENDAMUSTINE ALONE IN PATIENTS WITH RITUXIMAB-REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE GADOLIN STUDY

EHA Library, Marek Trneny, 135196

A PHASE I/II STUDY OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS GENETICALLY MODIFIED WITH GLOBE LENTIVIRAL VECTOR FOR THE TREATMENT OF TRANSFUSION DEPENDENT BETA-THALASSEMIA

EHA Library, Sarah Marktel, 135221

A NOVEL EPIGENETIC RESISTANCE MECHANISM TO THE FLT3 INHIBITOR PKC412 INDUCES CROSS-RESISTANCE TO STANDARD CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Stefanie Göllner, 135216

HIGH GENE EXPRESSION OF HIST1H2AG AND HIST1H4A REDUCES IMATINIB UPTAKE INTO CML CELLS AND PREDICTS POOR RESPONSE TO FRONTLINE IMATINIB THERAPY

EHA Library, Chung Hoow Kok, 135191

IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY

EHA Library, Graeme Fraser, 135186

DEFINING NEW THERAPEUTIC AGENTS THAT TARGET THE ONCOGENIC TRANSLATION PROGRAM IN MULTIPLE MYELOMA

EHA Library, Salomon Manier, 135205

HEDGEHOG SIGNALING PATHWAY INHIBITOR, PF-04449913 LIMITS THE SELF-RENEWAL OF MDS-DERIVED INDUCED POTENT STEM CELLS (IPSC): MOLECULAR MECHANISMS

EHA Library, Tetsuzo Tauchi, 135200

RUXOLITINIB (RUX) REDUCES JAK2V617F ALLELE BURDEN (AB) IN PATIENTS (PTS) WITH POLYCYTHEMIA VERA (PV) ENROLLED IN THE RESPONSE STUDY

EHA Library, Alessandro M. Vannucchi, 135210

THE RET RECEPTOR TYROSINE KINASE PROMOTES ACUTE MYELOID LEUKEMIA THROUGH PROTECTION OF FLT3-ITD MUTANTS FROM AUTOPHAGIC DEGRADATION

EHA Library, Saskia Rudat, 135215

SEQUENCE VARIANTS IN PATIENTS WITH PRIMARY AND ACQUIRED RESISTANCE TO IBRUTINIB IN THE PHASE 3 MCL3001 (RAY) TRIAL

EHA Library, Georg Lenz, 135195

THE EUTOS LONG-TERM SURVIVAL SCORE IS PREDICTIVE FOR RESPONSE AND OUTCOME IN CML PATIENTS TREATED FRONTLINE WITH NILOTINIB-BASED REGIMENS

EHA Library, Fausto Castagnetti, 135190

EVALUATION OF 243 PATIENTS WITH DELETION 17P CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB: A CROSS-STUDY ANALYSIS OF TREATMENT OUTCOMES

EHA Library, Jeffrey Jones, 135185